Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CCR5 | P51681 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.31 |
| ▸ | BCL2 | P10415 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5236422 | 1.00 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL5229323 | 0.87 | ALDH1A1 (0.32) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL5233019 | 0.85 | POLB (0.36) | ALDH1A1MAPTHPGDRAB9ANPC1 | |
| SCHEMBL7007006 | 0.84 | ALDH1A1 (0.32) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL5235449 | 0.84 | ALDH1A1 (0.32) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL5232065 | 0.83 | MCL1 (0.30) | MCL1L3MBTL1 | |
| SCHEMBL5233372 | 0.81 | PREP (0.41) | ALDH1A1MAPTHPGDRAB9ASMN1; SMN2 | |
| SCHEMBL6403333 | 0.80 | RAB9A (0.42) | ALDH1A1MAPTHPGDCCR5RAB9A | |
| SCHEMBL9520614 | 0.80 | MMP2 (0.43) | ALDH1A1MAPTHPGDCCR5MCL1 | |
| SCHEMBL9520648 | 0.79 | ALDH1A1 (0.39) | ALDH1A1MAPTHPGDCCR5RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040038967-A1 | Novel carbapenem derivatives | MEIJI SEIKI KAISHA, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038967-A1 | Novel carbapenem derivatives | DHPS, HAMP, MCRS1 | ALDH1A1 1076/4885MAPT 4499/4885HPGD 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.